Table 4.

Other secondary endpoints in the intention-to-treat analysis.

Parameter	Mean difference (95% CI)		P-value between arms
	e-coaching (n=60)	Control (n=60)
Fasting blood glucose, mmol/L	-0.14 (1.46)	0.11 (1.57)		.36
Uric acid, µmol/L	-6.37 (45.45)	-8.58 (42.29)		.78
Total cholesterol, mg/dL	0.0 (0.21)	-0.04 (0.32)		.40
LDL-C, mg/dL	0.03(0.20)	-0.02 (0.28)		.43
HDL-C, mg/dL	0.00 (0.05)	0.00 (0.06)		.78
Triglycerides, mg/dL	-0.22 (1.05)	-0.14 (0.50)		.67
hs-CRP, mg/L	-0.24 (1.48)	0.08 (2.01)		.81
Serum glutamic oxaloacetic transaminase, IU/L	-3.52 (10.41)	-0.17 (12.63)		.13
Serum glutamic pyruvic transaminase, IU/L	-1.78 (6.76)	-1.28 (7.61)		.70
Gammaglutamyl-transferases, IU/L	-2.13 (20.62)	2.97 (17.73)		.47